PSYENCE BIOMEDICAL LTD (PBMWW) Free cash flow 2024–2025
PSYENCE BIOMEDICAL LTD (PBMWW) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$3.7MFY2025 · since FY2024: -$3.0M → -$3.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.7M | -26.9% |
| FY2024 | -$3.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More PBMWW financial trends
PBMWW RevenuePBMWW Net incomePBMWW Net marginPBMWW Gross profitPBMWW Gross marginPBMWW Operating incomePBMWW Operating marginPBMWW Operating cash flowPBMWW Capital expendituresPBMWW Return on equityPBMWW Stock buybacksPBMWW Dividends paidPBMWW Total assetsPBMWW Total liabilitiesPBMWW Shareholders’ equityPBMWW overview →